Antidepressant specificity of serotonin transporter suggested by three LeuT–SSRI structures

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Structural &Molecular Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nsmb.1602PMID 19430461PMCID PMC2758934
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation

  2009cited by this paper
• Structure and localisation of drug binding sites on neurotransmitter transporters

  2009cited by this paper
• Sodium-coupled neurotransmitter transporters.

  2008cited by this paper
• From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.

  2008cited by this paper
• A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation

  2008cited by this paper
• Comparative Molecular Field Analysis Using Selectivity Fields Reveals Residues in the Third Transmembrane Helix of the Serotonin Transporter Associated with Substrate and Antagonist Recognition

  2008cited by this paper
• Salt-bridge dynamics control substrate-induced conformational change in the membrane transporter GlpT.

  2008cited by this paper
• The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.

  2008cited by this paper
• Fluorine in Pharmaceuticals: Looking Beyond Intuition

  2007cited by this paper
• LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake

  2007cited by this paper
• Identification of a chloride ion binding site in Na+/Cl−-dependent transporters

  2007cited by this paper
• Mechanism of chloride interaction with neurotransmitter:sodium symporters

  2007cited by this paper
• Antidepressant binding site in a bacterial homologue of neurotransmitter transporters

  2007cited by this paper
• Monitoring the function of membrane transport proteins in detergent-solubilized form

  2007cited by this paper
• Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.

  2007cited by this paper
• Getting the message across: a recent transporter structure shows the way.

  2006cited by this paper
• Neurotransmitter transporters and their impact on the development of psychopharmacology

  2006cited by this paper
• Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants*

  2006cited by this paper
• Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters

  2005cited by this paper
• High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.

  2005cited by this paper
• Aspartate 345 of the Dopamine Transporter Is Critical for Conformational Changes in Substrate Translocation and Cocaine Binding*

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.

  2003cited by this paper
• Plasma membrane monoamine transporters: structure, regulation and function

  2003cited by this paper
• Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis.

  2003cited by this paper
• Characterization of a Functional Bacterial Homologue of Sodium-dependent Neurotransmitter Transporters*

  2003cited by this paper
• Functional Characterization of Cysteine Residues in GlpT, the Glycerol 3-Phosphate Transporter of Escherichia coli

  2003cited by this paper
• The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP‐treated and levodopa‐primed common marmosets

  2002cited by this paper
• Mechanisms of Biogenic Amine Neurotransmitter Transporters

  2002cited by this paper
• Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.

  2001cited by this paper
• Neurochemical neutralization of methamphetamine with high‐affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

  2000cited by this paper
• Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

  1999cited by this paper
• Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

  1999cited by this paper
• The absolute configuration of sertraline (Zoloft) hydrochloride

  1999cited by this paper
• Gelatinase B: Structure, Regulation, and Function

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.

  1998cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  1997cited by this paper
• Cloning and expression of the mouse serotonin transporter.

  1996cited by this paper
• Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.

  1996cited by this paper
• Development of Antidepressant Drugs

  1995cited by this paper
• Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors.

  1995cited by this paper
• Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication.

  1995cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Third‐generation antidepressants

  1993cited by this paper
• Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor.

  1988cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins.

  1984cited by this paper
• The pharmacological basis of therapeutics.

  1975cited by this paper

• Effects of Selective Serotonin Reuptake Inhibitors (SSRI) on the Placenta†.

  2025cites this paper
• Serotonin 2A receptor attenuates psoriatic inflammation by suppressing IL-23 secretion in monocyte-derived Langerhans cells

  2025cites this paper
• Systematic metaproteomics mapping reveals functional and ecological landscapes of Ex vivo human gut microbiota responses to therapeutic drugs

  2025cites this paper
• Perinatal citalopram exposure alters the gut composition and microbial metabolic profiles of Sprague-Dawley rat dams and female offspring but not male offspring

  2025cites this paper
• Streamlined Atom-Economical Synthesis of Escitalopram: Kilogram-Scale Process Optimization and Industrial-Scale Implementation

  2025cites this paper
• Differential effects of acute and chronic fluoxetine on c-Fos expression in specific subpopulations of midbrain dopaminergic neurons.

  2025cites this paper
• Molecular basis for the effects of SSRIs in non-target aquatic invertebrates: A case study with Mytilus galloprovincialis early larvae.

  2025cites this paper
• GC–MS Analysis, Neuropharmacological, and Antidiarrheal Activities of the Acetone Extract of Najas gracillima Seaweed: In Vivo and In Silico Study

  2024cites this paper
• Proteochemometric modeling strengthens the role of Q299 for GABA transporter subtype selectivity

  2024cites this paper
• Structural Models of Human Norepinephrine Transporter Ensemble Reveal the Allosteric Sites and Ligand-Binding Mechanism.

  2024cites this paper
• Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)

  2024cites this paper
• Deciphering the Role of siRNA in Anxiety and Depression.

  2024cites this paper
• Uncovering the Elusive Structures and Mechanisms of Prevalent Antidepressants

  2024cites this paper
• Substituted Indole Derivatives against Leucine Transporter (LeuT) as SSRI Antidepressant: Molecular Dynamics Study

  2024cites this paper
• Cryo‐EM structure of the dopamine transporter with a novel atypical non‐competitive inhibitor bound to the orthosteric site

  2024cites this paper
• Psilocybin in pharmacotherapy of obsessive-compulsive disorder

  2024cites this paper
• Fluvoxamine: First comprehensive insights into its molecular characteristics and inclusion complexation with β-cyclodextrin

  2024cites this paper
• Synthesis, Spectral Characterization, Density Functional Theory Investigation and Molecular Docking Studies of Formohydrazide‐Based Hydrazones as Potential Antimicrobial Agents

  2023cites this paper
• Taurine and Creatine Transporters as Potential Drug Targets in Cancer Therapy

  2023cites this paper
• (2-Cyclohexyl-1-methylpropyl) cyclohexane isolated from garlic extract exhibits antidepressant-like activity: extraction, docking, drug-like properties, molecular dynamics simulations and MM/GBSA studies

  2023cites this paper
• Resting-state functional connectivity of the raphe nuclei in major depressive Disorder: A Multi-site study

  2023cites this paper
• Carbazole derivatives as promising competitive and allosteric inhibitors of human serotonin transporter: computational pharmacology

  2023influential citation
• One-Stage Chiral Enrichment Process by Continuous Flow Electrodialysis with Molecularly Imprinted Membrane

  2022cites this paper
• Effects of prenatal exposure to fluoxetine on circadian rhythmicity in the locomotor activity and neuropeptide Y and 5‐HT expression in male and female adult Wistar rats

  2022cites this paper
• A multidimensional strategy for uncovering comprehensive quality markers of Schisandra chinensis (Turcz.) Baill based on pharmacodynamics and chemical properties.

  2022cites this paper
• Novel Molecular Targets of Antidepressants

  2022cites this paper
• The serotonin theory of depression: a systematic umbrella review of the evidence

  2022cites this paper
• Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex

  2022cites this paper
• Interactions between maternal fluoxetine exposure, the maternal gut microbiome and fetal neurodevelopment in mice.

  2021cites this paper
• Structural Determinants of the Neuronal Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543

  2021cites this paper
• Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.

  2021cites this paper
• Advancing insights on β-cyclodextrin inclusion complexes with SSRIs through lens of X-ray diffraction and DFT calculation

  2021cites this paper
• Truly‐Biocompatible Gold Catalysis Enables Vivo‐Orthogonal Intra‐CNS Release of Anxiolytics

  2021cites this paper
• Factors related to age at depression onset: the role of SLC6A4 methylation, sex, exposure to stressful life events and personality in a sample of inpatients suffering from major depression

  2021cites this paper
• Glycine Transporter 2: Mechanism and Allosteric Modulation

  2021cites this paper
• Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Developing Neural Circuits in a Model of the Human Fetal Cortex

  2021cites this paper
• Classical targets in drug discovery

  2021cites this paper
• Truly‐Biocompatible Gold Catalysis Enables Vivo‐Orthogonal Intra‐CNS Release of Anxiolytics

  2021cites this paper
• Acute Angle-Closure—A Rare but Vision-Threatening Ocular Adverse Effect of Selective Serotonin Reuptake Inhibitors

  2021cites this paper
• Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.

  2021cites this paper
• Synthesis, Molecular Docking, Druglikeness Analysis, and ADMET Prediction of the Chlorinated Ethanoanthracene Derivatives as Possible Antidepressant Agents

  2020cites this paper
• Understanding the Contribution of Individual Amino Acid Residues in the Binding of Psychoactive Substances to Monoamine Transporters

  2020cites this paper
• Involvement of protein kinase C beta1-serotonin transporter system dysfunction in emotional behaviors in stressed mice.

  2020cites this paper
• In silico Analysis and Molecular Docking of Newly Synthesized Chlorinated Tetracyclic as Antidepressant Agents

  2020cites this paper
• Toward a Systematic Structural and Functional Annotation of Solute Carriers Transporters—Example of the SLC6 and SLC7 Families

  2020cites this paper
• Thymoquinone harbors protection against Concanavalin A-induced behavior deficit in BALB/c mice model.

  2020cites this paper
• Structure-Function of the High Affinity Substrate Binding Site (S1) of Human Norepinephrine Transporter

  2020cites this paper
• Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression

  2020cites this paper
• University of Groningen Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression Ramsteijn,

  2020cites this paper
• Identification of a New Allosteric Binding Site for Cocaine in Dopamine Transporter

  2020cites this paper
• γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases.

  2020cites this paper
• Profiling the antidepressant properties of phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET predictions.

  2020cites this paper
• Structure Modeling of the Norepinephrine Transporter

  2020cites this paper
• Identification of the benztropine analog [125I]GA II 34 binding site on the human dopamine transporter.

  2019cites this paper
• Monoamine transporters: structure, intrinsic dynamics and allosteric regulation

  2019cites this paper
• Increased Serotonin Transporter Expression in Huntington’s Disease Patients Is Not Consistently Replicated in Murine Models

  2019cites this paper
• GPathFinder: Identification of Ligand-Binding Pathways by a Multi-Objective Genetic Algorithm

  2019cites this paper
• Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS

  2019cites this paper
• System Xc− Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine

  2019cites this paper
• Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior

  2019cites this paper
• Sertraline inhibits nerve growth factor‐induced neurite outgrowth in PC12 cells via a mechanism involving the sigma‐1 receptor

  2019cites this paper
• Insights into the mechanism and pharmacology of neurotransmitter sodium symporters.

  2019cites this paper
• A structural model of the human serotonin transporter in an outward-occluded state

  2019cites this paper
• Is protein structure enough? A review of the role of lipids in SLC6 transporter function.

  2019cites this paper
• Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies.

  2019cites this paper
• Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

  2018influential citation
• Molecular and functional characterization of the Gulf toadfish serotonin transporter SLC6A4

  2018cites this paper
• In silico Description of LAT1 Transport Mechanism at an Atomistic Level

  2018cites this paper
• Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective

  2018cites this paper
• The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites

  2018cites this paper
• Modification of a Putative Third Sodium Site in the Glycine Transporter GlyT2 Influences the Chloride Dependence of Substrate Transport

  2018cites this paper
• Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation

  2018cites this paper
• 3D similarities between the binding sites of monoaminergic target proteins

  2018cites this paper
• Exploring Substrate Binding in the Extracellular Vestibule of MhsT by Atomistic Simulations and Markov Models

  2018cites this paper
• Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT1A receptor agonistic activity.

  2018cites this paper
• Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study

  2018cites this paper
• Early-Life Exposure to the Antidepressant Fluoxetine Induces a Male-Specific Transgenerational Disruption of the Stress Axis and Exploratory Behavior in Adult Zebrafish, Danio rerio

  2018influential citation
• The dopamine transporter role in psychiatric phenotypes

  2018cites this paper
• Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters.

  2018cites this paper
• Analytical methodologies for the stereoselective determination of fluoxetine: An overview.

  2018cites this paper
• Computational study of SERT using new X-ray crystal structures and initial experimental verification of potential GABAB receptor compounds

  2018cites this paper
• Modeling and Design for Membrane Protein Targets

  2017cites this paper
• An AOP analysis of selective serotonin reuptake inhibitors (SSRIs) for fish.

  2017cites this paper
• Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2.

  2017cites this paper
• The Molecular Basis of the Interaction Between Drugs and Neurotransmitter Transporters

  2017cites this paper
• Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression Dopamine Transporter and Reward Anticipation in a Dimensional Perspective : A Multimodal Brain Imaging Study

  2017cites this paper
• Structural basis for recognition of diverse antidepressants by the human serotonin transporter

  2017cites this paper
• Potentiating SLC transporter activity: Emerging drug discovery opportunities

  2017cites this paper
• In Silico Studies Revealed Multiple Neurological Targets for the Antidepressant Molecule Ursolic Acid

  2017cites this paper
• Interaction of Cocaine Analogue RTI82 With the Dopamine Transporter

  2017cites this paper
• The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state

  2017cites this paper
• New Trends in Antidepressant Drug Research

  2017cites this paper
• Direct assessment of substrate binding to the Neurotransmitter:Sodium Symporter LeuT by solid state NMR

  2017cites this paper
• Computational and biological evidences on the serotonergic involvement of SeTACN antidepressant-like effect in mice

  2017cites this paper
• Structural biology of solute carrier (SLC) membrane transport proteins

  2017cites this paper
• X-ray structures and mechanism of the human serotonin transporter

  2016cites this paper
• Synthesis and inhibitory evaluation of 3-linked imipramines for the exploration of the S2 site of the human serotonin transporter.

  2016cites this paper
• From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter

  2016cites this paper
• Structure–activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5‐HT transporter

  2016influential citation
• Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature.

  2016cites this paper